Melatonin in perimenopause: does it help?

Melatonin is one of the first things women reach for when perimenopause starts breaking up their sleep, and for most of them it does little. The hormone tells your body when night is, but it does not stop a night sweat, quiet a racing mind or keep an airway open, which are the usual reasons for waking after 40. Guidelines do not recommend it for chronic insomnia, and the trials in menopausal women are unimpressive. It has a narrow, legitimate use for timing problems, and it is generally safe for short-term use, provided you know that what is in the bottle often does not match the label.

What melatonin is

Melatonin is a hormone your brain’s pineal gland releases in response to darkness. Its job is to signal the time of day to the rest of the body, which helps anchor the 24-hour circadian rhythm. Natural levels rise in the evening, stay elevated overnight and fall with morning light.

Taken as a supplement, melatonin shifts or reinforces that signal. It is not a sedative in the way a sleeping pill is: it does not force sleep, and in people whose timing is already normal, adding more produces only a small effect. In the US it is sold as a dietary supplement, which means, as the FDA explains, it does not need approval before it is marketed. Manufacturers are responsible for the safety and labeling of their products, and the FDA acts only after a problem reaches the market.

Why perimenopause sleep problems are usually not a melatonin problem

The sleep disruption of perimenopause has well-described causes, and timing is rarely one of them. Night sweats wake women directly. Falling estradiol and rising FSH are independently linked to trouble falling and staying asleep. Anxiety and low mood, which become more common in the transition, keep the mind alert at 3 a.m. Sleep apnea risk rises after menopause and often presents as insomnia in women. None of these is fixed by telling the body it is nighttime; the body already knows.

This is why the American Academy of Sleep Medicine’s pharmacologic guideline suggests clinicians not use melatonin for either sleep-onset or sleep-maintenance insomnia. The task force judged that the evidence for benefit was lacking and that systematic data on side effects were unavailable, so benefits and harms were roughly in balance. The National Center for Complementary and Integrative Health (NCCIH) summarizes the same position: guidelines from the AASM and the American College of Physicians do not find enough evidence to recommend melatonin for chronic insomnia, and recommend cognitive behavioral therapy instead.

If early-hours waking is your pattern, why perimenopause wakes you at 3 a.m. explains the mechanics.

What the evidence in menopausal women shows

Two systematic reviews have looked specifically at this group.

A 2021 review in the Journal of Pineal Research pooled 24 interventional studies with 1,173 participants. It found that melatonin improved EEG patterns and subjective sleep quality in postmenopausal women who already had sleep impairment, and that doses of 3 mg and above improved menopausal symptoms in one or more domains. It also noted that VLDL cholesterol and triglycerides tended to rise during melatonin use, and that bone density and body mass index results looked favorable. The authors were positive overall, but the studies were small and varied.

A 2026 meta-analysis restricted to randomized controlled trials from 2015 to 2024 reached a more cautious conclusion. Across seven trial groups and 497 participants, melatonin showed no significant improvement in sleep quality, menopausal symptoms, anxiety, depression, sexual function or body weight. The one signal was a possible increase in bone mineral density at the femoral neck, based on two trials, and the authors could not separate melatonin’s own effect from the combination products often used.

Taken together: a modest effect on subjective sleep in some postmenopausal women with existing sleep problems is possible, but the better-controlled recent evidence does not confirm it, and there is no evidence that melatonin addresses the perimenopausal drivers of waking.

Where melatonin may help

The NCCIH lists the situations with the best support: jet lag, especially after eastward travel; delayed sleep-wake phase disorder, where the body clock runs late and you cannot fall asleep or wake at conventional times; and anxiety before and after surgery. Evidence for shift work is small and inconclusive.

If you fall asleep easily but at 2 a.m., and you can sleep soundly until 10 a.m. when allowed, you may have a timing problem that melatonin, taken in the early evening along with morning light, can help shift. If you fall asleep fine and wake at 3 a.m. hot or anxious, you do not.

Dose, safety and product quality

Safety. The NCCIH considers short-term use safe for most adults. Reported side effects are mild: headache, dizziness and nausea. Long-term safety has not been established. People taking blood thinners and people with epilepsy should talk to a clinician before using it, and anyone on prescription medication should ask about interactions.

Dose. No dose is established for perimenopause. More is not better for a timing signal, and the trials in menopausal women do not show that higher doses work better.

What is actually in the product. This is the practical problem. A 2023 analysis in JAMA tested 25 melatonin gummy products sold in the US. Twenty-two (88%) were inaccurately labeled; actual melatonin content ranged from 74% to 347% of the labeled amount, and one product contained no melatonin at all but 31 mg of CBD. The NCCIH also cites a 2017 study in which the melatonin content of most products did not match the label and 26% contained serotonin, a related compound that should not be in a supplement. If you choose to use melatonin, a product verified by an independent testing program is the only way to know roughly what you are taking.

For comparison with another popular sleep supplement, see magnesium glycinate.

What to do instead

The ranking is clear from the guidelines:

1. CBT-I is the strongly recommended treatment for chronic insomnia and has been tested in menopausal women. See CBT-I for menopause insomnia.
2. Treat the trigger. If night sweats are waking you, hormone therapy or an evidence-based nonhormone option for hot flashes addresses the cause. See hormone therapy and sleep.
3. Rule out sleep apnea if you wake unrefreshed, have morning headaches or snore. See sleep apnea in women after 40.
4. Use melatonin only for timing problems, short term, from a tested product.

Two weeks with a sleep diary will usually show which category you are in.

When to see a clinician

See a clinician if poor sleep has lasted more than a few weeks and is affecting your days, or sooner if you have:

• Snoring, gasping or witnessed pauses in breathing, or daytime sleepiness
• Low mood, loss of interest or anxiety that is hard to control
• Thoughts of harming yourself (call or text 988, the Suicide & Crisis Lifeline)
• Side effects from any supplement, which you can also report to the FDA

A sleep medicine specialist can arrange CBT-I and testing. For hot flashes and hormone questions, see an ob-gyn or use how to find a menopause specialist. The symptom check can help you prepare.